يعرض 1 - 20 نتائج من 146 نتيجة بحث عن '"interleukin 10/ec [Endogenous Compound]"', وقت الاستعلام: 0.55s تنقيح النتائج
  1. 1
    Electronic Resource
  2. 2
    Electronic Resource

    المؤلفون: Sobey C.G., Phan T.G., Zhang S.R.

    مصطلحات الفهرس: disease association, disease severity, down regulation, encephalitis/co [Complication], encephalitis/dt [Drug Therapy], encephalitis/pc [Prevention], endothelium cell, functional status, hormone release, human, immune deficiency, immunoreactivity, immunosuppressive treatment, innate immunity, intracellular signaling, lymphocytopenia/co [Complication], mechanical thrombectomy, microglia, neuroimaging, neuroprotection, neutrophil lymphocyte ratio, nonhuman, priority journal, protein expression, regulatory T lymphocyte, review, Th1 cell, Th17 cell, Th2 cell, upregulation, 1 (2 bromophenyl) 3 (2 hydroxy 4 nitrophenyl)urea/dt [Drug Therapy], alteplase/dt [Drug Therapy], apocynin/dt [Drug Therapy], beta 2 adrenergic receptor/ec [Endogenous Compound], CD14 antigen/ec [Endogenous Compound], CD16 antigen/ec [Endogenous Compound], chemokine receptor CCR2/ec [Endogenous Compound], colony stimulating factor 1/ec [Endogenous Compound], colony stimulating factor receptor/ec [Endogenous Compound], corticotropin/ec [Endogenous Compound], corticotropin releasing factor/ec [Endogenous Compound], CXCL1 chemokine/ec [Endogenous Compound], CXCL2 chemokine/ec [Endogenous Compound], disufenton sodium/dt [Drug Therapy], endothelial leukocyte adhesion molecule 1/ec [Endogenous Compound], gamma interferon/ec [Endogenous Compound], heat shock protein/ec [Endogenous Compound], high mobility group B1 protein/ec [Endogenous Compound], immunoglobulin enhancer binding protein/ec [Endogenous Compound], intercellular adhesion molecule 1/ec [Endogenous Compound], interleukin 1 receptor like 1 protein/ec [Endogenous Compound], interleukin 10/ec [Endogenous Compound], interleukin 17/ec [Endogenous Compound], interleukin 18/ec [Endogenous Compound], interleukin 1beta/ec [Endogenous Compound], interleukin 33/ec [Endogenous Compound], interleukin 37/ec [Endogenous Compound], interleukin 4/ec [Endogenous Compound], interleukin 6/ec [Endogenous Compound], matrix metalloproteinase/ec [Endogenous Compound], mifepristone/dt [Drug Therapy], monocyte chemotactic protein 1/ec [Endogenous Compound], PADGEM protein/ec [Endogenous Compound], pattern recognition receptor/ec [Endogenous Compound], propranolol/dt [Drug Therapy], protein kinase C delta/ec [Endogenous Compound], reactive oxygen metabolite/ec [Endogenous Compound], tenecteplase/dt [Drug Therapy], toll like receptor/ec [Endogenous Compound], toll like receptor 1/ec [Endogenous Compound], tumor necrosis factor/ec [Endogenous Compound], unclassified drug, uridine triphosphate/ec [Endogenous Compound], vascular cell adhesion molecule 1/ec [Endogenous Compound], stent retriever, colony stimulating factor 1 receptor/ec [Endogenous Compound], toll like receptor 13/ec [Endogenous Compound], immunocompetent cell, adaptive immunity, antigen expression, apoptosis, blood brain barrier, brain blood flow, brain infarction size, brain ischemia/dt [Drug Therapy], brain ischemia/su [Surgery], catecholamine release, cell activation, cell infiltration, cell interaction, cellular immunity, complement activation, cytokine release, Review

    URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/27422
    Trends in Pharmacological Sciences
    Click here for full text options
    LibKey Link

  3. 3
    Electronic Resource
  4. 4
    Electronic Resource

    المؤلفون: Sobey C.G., Phan T.G., Zhang S.R.

    مصطلحات الفهرس: disease association, disease severity, down regulation, encephalitis/co [Complication], encephalitis/dt [Drug Therapy], encephalitis/pc [Prevention], endothelium cell, functional status, hormone release, human, immune deficiency, immunoreactivity, immunosuppressive treatment, innate immunity, intracellular signaling, lymphocytopenia/co [Complication], mechanical thrombectomy, microglia, neuroimaging, neuroprotection, neutrophil lymphocyte ratio, nonhuman, priority journal, protein expression, regulatory T lymphocyte, review, Th1 cell, Th17 cell, Th2 cell, upregulation, 1 (2 bromophenyl) 3 (2 hydroxy 4 nitrophenyl)urea/dt [Drug Therapy], alteplase/dt [Drug Therapy], apocynin/dt [Drug Therapy], beta 2 adrenergic receptor/ec [Endogenous Compound], CD14 antigen/ec [Endogenous Compound], CD16 antigen/ec [Endogenous Compound], chemokine receptor CCR2/ec [Endogenous Compound], colony stimulating factor 1/ec [Endogenous Compound], colony stimulating factor receptor/ec [Endogenous Compound], corticotropin/ec [Endogenous Compound], corticotropin releasing factor/ec [Endogenous Compound], CXCL1 chemokine/ec [Endogenous Compound], CXCL2 chemokine/ec [Endogenous Compound], disufenton sodium/dt [Drug Therapy], endothelial leukocyte adhesion molecule 1/ec [Endogenous Compound], gamma interferon/ec [Endogenous Compound], heat shock protein/ec [Endogenous Compound], high mobility group B1 protein/ec [Endogenous Compound], immunoglobulin enhancer binding protein/ec [Endogenous Compound], intercellular adhesion molecule 1/ec [Endogenous Compound], interleukin 1 receptor like 1 protein/ec [Endogenous Compound], interleukin 10/ec [Endogenous Compound], interleukin 17/ec [Endogenous Compound], interleukin 18/ec [Endogenous Compound], interleukin 1beta/ec [Endogenous Compound], interleukin 33/ec [Endogenous Compound], interleukin 37/ec [Endogenous Compound], interleukin 4/ec [Endogenous Compound], interleukin 6/ec [Endogenous Compound], matrix metalloproteinase/ec [Endogenous Compound], mifepristone/dt [Drug Therapy], monocyte chemotactic protein 1/ec [Endogenous Compound], PADGEM protein/ec [Endogenous Compound], pattern recognition receptor/ec [Endogenous Compound], propranolol/dt [Drug Therapy], protein kinase C delta/ec [Endogenous Compound], reactive oxygen metabolite/ec [Endogenous Compound], tenecteplase/dt [Drug Therapy], toll like receptor/ec [Endogenous Compound], toll like receptor 1/ec [Endogenous Compound], tumor necrosis factor/ec [Endogenous Compound], unclassified drug, uridine triphosphate/ec [Endogenous Compound], vascular cell adhesion molecule 1/ec [Endogenous Compound], stent retriever, colony stimulating factor 1 receptor/ec [Endogenous Compound], toll like receptor 13/ec [Endogenous Compound], immunocompetent cell, adaptive immunity, antigen expression, apoptosis, blood brain barrier, brain blood flow, brain infarction size, brain ischemia/dt [Drug Therapy], brain ischemia/su [Surgery], catecholamine release, cell activation, cell infiltration, cell interaction, cellular immunity, complement activation, cytokine release, Review

    URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/27422
    Trends in Pharmacological Sciences
    LibKey Link

  5. 5
    Electronic Resource

    URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/28950
    Gastroenterology
    Click here for full text options
    LibKey Link

  6. 6
    Electronic Resource

    URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/29256
    Pharmacological Research
    Click here for full text options
    LibKey Link

  7. 7
    Electronic Resource

    URL: Allergy: European Journal of Allergy and Clinical Immunology
    Click here for full text options
    LibKey Link

  8. 8
    Electronic Resource
  9. 9
    Electronic Resource
  10. 10
    Electronic Resource
  11. 11
    Electronic Resource
  12. 12
    Electronic Resource

    مصطلحات الفهرس: toll like receptor 4/ec [Endogenous Compound], toll like receptor 5/ec [Endogenous Compound], toll like receptor 6/ec [Endogenous Compound], toll like receptor 7/ec [Endogenous Compound], toll like receptor 8/ec [Endogenous Compound], toll like receptor 9/ec [Endogenous Compound], transcription factor GATA 3/ec [Endogenous Compound], transcription factor T bet/ec [Endogenous Compound], transforming growth factor beta/ec [Endogenous Compound], toll like receptor 11/ec [Endogenous Compound], adult, animal cell, animal experiment, animal model, article, controlled study, human, human tissue, immunology, infant, innate immunity, intestine injury, low birth weight, lymphoid cell, male, microbial diversity, monocyte, mortality rate, mouse, necrotizing enterocolitis/et [Etiology], newborn, nonhuman, pneumatosis intestinalis, prematurity, Th17 cell, CXCL1 chemokine/ec [Endogenous Compound], interleukin 1 receptor/ec [Endogenous Compound], interleukin 10/ec [Endogenous Compound], interleukin 17/ec [Endogenous Compound], interleukin 17F/ec [Endogenous Compound], interleukin 18/ec [Endogenous Compound], interleukin 1beta/ec [Endogenous Compound], interleukin 21/ec [Endogenous Compound], interleukin 22/ec [Endogenous Compound], interleukin 23/ec [Endogenous Compound], interleukin 37/ec [Endogenous Compound], interleukin 4/ec [Endogenous Compound], interleukin 6/ec [Endogenous Compound], messenger RNA/ec [Endogenous Compound], natural cytotoxicity triggering receptor 1/ec [Endogenous Compound], retinoid related orphan receptor gamma/ec [Endogenous Compound], toll like receptor 1/ec [Endogenous Compound], toll like receptor 10/ec [Endogenous Compound], toll like receptor 2/ec [Endogenous Compound], toll like receptor 3/ec [Endogenous Compound], Article

  13. 13
    Electronic Resource
  14. 14
    Electronic Resource

    URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/29014
    Allergy: European Journal of Allergy and Clinical Immunology
    LibKey Link

  15. 15
    Electronic Resource
  16. 16
    Electronic Resource
  17. 17
    Electronic Resource
  18. 18
    Electronic Resource

    المؤلفون: Flynn J.K., Morand E.F., Dankers W.

    URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/35608
    Frontiers in Immunology
    Click here for full text options
    LibKey Link

  19. 19
  20. 20